227.999 Cost of Drug Disclosure During Direct Advertising: MSSNY has adopted the position that pharmaceutical companies include in the consumer advertisement of any pharmaceutical the suggested retail price of such pharmaceutical. (HOD 2001-51; Reaffirmed HOD 2003-252; Reaffirmed HOD 2013; Reaffirmed HOD 2023)
227.998 Regulation of Media Advertising of Prescription Drugs: SUNSET HOD 2014
227.997 Pharmaceutical Advertising: SUNSET HOD 2020
227.996 Attorney Ads on Drug Side Effects For attorney commercials that may cause patients to discontinue medically necessary medications, MSSNY, by legislation and/or regulation, will seek to require appropriate warnings that patients should not discontinue medications without seeking the advice of their physician. MSSNY will introduce a similar resolution to the AMA. (HOD 2016-211)
